Skip to content
GLP-1 Calculators

Compounded GLP-1 Cost in 2026 — Semaglutide & Tirzepatide vs Branded Self-Pay

Compare compounded semaglutide and tirzepatide pricing against Wegovy, Zepbound, LillyDirect, NovoCare, and retail cash — with the FDA status and safety caveats you actually need.

Updated April 2026

Medical disclaimer: This tool is for informational purposes. Not medical advice. Consult your healthcare provider before starting, stopping, or changing any medication. Drug prices, savings cards, and coverage policies change frequently — verify current pricing directly with the manufacturer or your pharmacy.

Your inputs

Results

Compounded 12-mo total
$3,588
$299/mo
Save vs brand pen
$12,600
Save vs mfg vial
$2,400
Compounded GLP-1s are not FDA-approved. Safety, potency, and sterility vary by pharmacy. Use only state-licensed 503A pharmacies, verify via NABP, and discuss with your clinician.

Typical price points (2026)

  • Compounded semaglutide: $199–$399/month.
  • Compounded tirzepatide: $249–$499/month.
  • Wegovy list (pen): ~$1,349/month AWP. Commercial copays vary.
  • NovoCare self-pay (Wegovy vial): ~$499/month delivered.
  • LillyDirect self-pay (Zepbound vial): $349/mo at 2.5 mg; $499/mo at 5–10 mg.
  • Zepbound list (pen): ~$1,086/month.
  • Ozempic retail cash: ~$999–$1,529/month with coupons.
  • Mounjaro retail cash: ~$1,000–$1,135/month with coupons.

The headline savings — compounded sema at $299 vs Wegovy list at $1,349 — is real on paper. The savings against manufacturer self-pay programs (NovoCare $499, LillyDirect $349–$499) are much narrower and often not worth the regulatory and quality tradeoff.

What you’re actually buying

A compounded sterile injection is the API (semaglutide base or tirzepatide base) reconstituted in bacteriostatic water, at a concentration specified on the prescription. Practical concerns:

  • Salt forms: FDA stated compounded GLP-1s must use the same base molecule as approved drug. Sodium or acetate salts are a red flag.
  • API sourcing: most compounders source from Chinese or Indian manufacturers. Demand a COA showing ≥99% purity + endotoxin testing.
  • Concentration and fill volume: 5 mL vial at 10 mg/mL = 50 mg. Different pharmacies use different concentrations; this matters for dosing.
  • Additives: B12 or NAD+ are marketing additions with no evidence. Pure API is preferable.

The comparison most patients should actually run

  1. Your insured copay on Wegovy or Zepbound, if covered. With savings cards, many commercial patients pay $0–$25. Beats compounded on cost and wins on quality.
  2. NovoCare $499 or LillyDirect $349–$499, if not covered. Manufacturer’s answer to compounded. Paying $200 more/mo for FDA-approved product is usually the right call.
  3. Compounded $249–$399, if the above are unavailable. The only scenario where math truly favors compounding is uninsured patients who can’t qualify for Novo/Lilly patient assistance, or patients with repeated PA denials.

Dosing errors are more common with compounded

Branded Wegovy ships as five pre-filled pens (0.25, 0.5, 1.0, 1.7, 2.4 mg). Zepbound ships at 2.5, 5, 7.5, 10, 12.5, 15 mg. Compounded typically dispenses multi-dose vials at one concentration, leaving the patient to draw units with an insulin syringe. A Reddit community analysis counted over 200 self-reported 10× overdose events in 2023–2024 from misreading unit marks. If you use compounded, have your prescriber or pharmacist walk you through unit-to-mg conversion explicitly.

Related tools
Generic vs brand
Full side-by-side comparison.
LillyDirect cost
Self-pay Zepbound vials.
HSA/FSA GLP-1
Pre-tax dollar arithmetic.
Monthly budget
All-in cost with visits + labs.
Cost per pound lost
Cost/efficacy tradeoff.
Telehealth vs clinic
Compounded distribution paths.

Frequently asked questions

Is compounded semaglutide bioequivalent to Wegovy?

There's no FDA-required bioequivalence testing for compounded products. PK studies on compounded sema are scarce. Assume they work similarly if the API is genuine and correctly dosed, but confirm response with the scale, waist tape, and your clinician. If you're not seeing trial-comparable TBWL by month 4 on a therapeutic dose, switch to the branded product.

What changed after the FDA declared shortages resolved?

In October 2024 FDA declared the tirzepatide shortage resolved, triggering 60-day (503A) / 90-day (503B) wind-downs. February 2025 FDA declared the semaglutide shortage resolved. Eli Lilly and Novo Nordisk have since pursued aggressive enforcement. Legitimate 503A pharmacies still compound GLP-1s for patient-specific clinical reasons (allergy to an excipient, non-commercially-available dose), but the economics and legal risk have shifted significantly.

Does my HSA cover compounded tirzepatide?

Generally yes, if your HSA custodian accepts prescription receipts from a licensed pharmacy. The IRS defines eligible medical expenses broadly; a prescribed compounded medication for an obesity diagnosis qualifies. Save the prescription, receipt, and the pharmacy's state license number for audit.

Will my prescriber keep writing compounded scripts?

Many won't. The legal landscape is narrow: 503A compounding is permitted for patient-specific reasons other than cost (excipient allergy, non-commercial strength). Some telehealth platforms have pivoted to NovoCare/LillyDirect referral or hybrid models. If your prescriber still compounds, verify the documented clinical rationale.

Why is compounded cheaper if the molecule is the same?

Research, clinical trials, FDA approval, post-marketing safety, marketing, cardiovascular outcomes trials (SELECT, SUMMIT) cost Novo Nordisk and Lilly billions. Compounders shoulder none of those costs, carry no reimbursement contracts, no rebates, no DTC advertising. That's the price gap — and it's also why FDA's approval process matters for long-term safety.

How do I spot an unsafe compounded seller?

Red flags: (1) no physician visit before prescribing, (2) no state pharmacy license or out-of-country pharmacy, (3) peptide sold 'for research purposes only', (4) prices under $100/month (below API cost), (5) promises of 'microdose kits' or Ozempic-plus-something cocktails, (6) no certificate of analysis on request. If any of these are present, walk away.

What's the real price comparison vs manufacturer self-pay?

Compounded sema: $199–$399/mo. Compounded tirz: $249–$499/mo. NovoCare (Wegovy vial): $499/mo. LillyDirect (Zepbound vial): $349/mo at 2.5mg, $499/mo at 5–10mg. The gap vs branded self-pay is often $100–$150/mo — narrower than people realize. Given safety and quality questions, paying the manufacturer premium is usually the right call.

What's the difference between 503A and 503B?

503A are state-licensed compounders that fill patient-specific prescriptions under USP <797> (sterile) standards. FDA doesn't routinely inspect. 503B are FDA-registered outsourcing facilities inspected under cGMP — higher quality bar, higher cost. Most 503B facilities exited the GLP-1 market after shortage resolutions. Most telehealth GLP-1s are 503A.

Digital Dashboard Hub

Track your GLP-1 progress, weight loss, and health metrics

DDH has 54 health and wellness trackers — weight loss logs, BMI history, symptom tracking, and habit tools — built for your GLP-1 journey. Free 14-day trial.

Track your GLP-1 journey free →
Part of the Digital Dashboard Hub network
Powered byDigital Dashboard Hub— 250+ free tools

Calculators, trackers, and planners for creators, business, and wellness — all in one place.

Explore all 250+ tools →